Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05287373 · ClinicalTrials.gov registry record · NA
Clinical Study Of a Micro-Implantable Pulse Generator For The Treatment of Peripheral Neuropathic Pain
A NA study of Chronic Pain and Peripheral Neuralgia, sponsored by Nalu Medical.
- Active
- Registry status
- NA
- Development phase
- 89
- Enrollment target
- 11
- Study locations
NCT05287373: Active NA study of Chronic Pain and Peripheral Neuralgia, sponsored by Nalu Medical.
NCT05287373 is a NA study of Chronic Pain and Peripheral Neuralgia that is active but no longer recruiting, run by Nalu Medical. The registered enrollment target is 89 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (88% lower). The trial reports 11 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05287373, a NA study of Chronic Pain and Peripheral Neuralgia, is active but no longer recruiting, sponsored by Nalu Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
- 11
- Study locations
Study Summary
This post market study is being conducted to document the comparative effectiveness and safety of peripheral nerve stimulation plus conventional medical management versus conventional medical management alone in the treatment of chronic, intractable peripheral neuralgia of post-traumatic or post-surgical origin. This is a prospective, minimal risk, multi-center, randomized control trial.
Primary Outcome
Difference in responder rates between groups. Responder rate is defined as the percent of subjects with 50% or greater pain relief from baseline, based on the BPI-Q5 (NRS).
Conditions Studied
Interventions
- DEVICE Nalu Neurostimulation System for PNS
- OTHER conventional medical management
Study Locations (11)
California
- Comprehensive Spine & Pain Physicians - Burbank
- Pain Management and Injury Relief - Thousand Oaks
Oregon
- Pacific Sports and Spine - Eugene
- Columbia Pain Management - Milwaukie
Texas
- Pain Specialists of America - Austin
- Institute of Precision Pain Medicine - Corpus Christi
Arizona
- Arizona Pain Specialists - Scottsdale
Colorado
- DBPS Research LLC - Denver
District of Columbia
- International Spine, Pain & Performance Center - Washington D.C.
North Carolina
- The Center for Clinical Research - Winston-Salem
Washington
- Anesis Spine and Pain Care - Spokane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2022-02-23 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What the registry record for NCT05287373 still lists
NCT05287373 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Nalu Neurostimulation System for PNS is the first listed.
NCT05287373 lists 11 locations in 8 states (California, Oregon, Texas).
Frequently Asked Questions
What is clinical trial NCT05287373 about?
NCT05287373 is a clinical study titled "Clinical Study Of a Micro-Implantable Pulse Generator For The Treatment of Peripheral Neuropathic Pain". This post market study is being conducted to document the comparative effectiveness and safety of peripheral nerve stimulation plus conventional medical management versus conventional medical management alone in the treatment of chronic, intractable peripheral neuralgia of post-traumatic or post-sur...
What is the current status of trial NCT05287373?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 89 participants. The study started on 2022-02-23. Estimated completion is 2026-09-30.
What conditions does trial NCT05287373 study?
This clinical trial studies the following conditions: Chronic Pain, Peripheral Neuralgia.
What interventions are being tested in trial NCT05287373?
The interventions under investigation include: Nalu Neurostimulation System for PNS (DEVICE), conventional medical management (OTHER).
Who is sponsoring clinical trial NCT05287373?
This trial is sponsored by Nalu Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05287373 being conducted?
This trial has 11 study locations across Arizona, California, Colorado, District of Columbia, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05287373's enrollment target sits among peer trials
89 146th of 301 higher than 156 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI